Anticancer agent 180
Product Specifications
Target
Endogenous Metabolite
Related Pathways
Metabolism
Bioactivity
Anticanceragent 180 (compound 4) is a secondary metabolite found in fungal strains, extracted through physical interaction with streptomycetes. It possesses potential antitumor activity and can inhibit the migration of MDA-MB-231 breast cancer cells.
Molecular Formula
C26H37NO4
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
S8026-01A-ML650 100 µL
SUMO, Pan (Small Ubiquitin-related Modifier 1, SUMO-1, Ubiquitin-like Protein SMT3C, SMT3 Homolog 3, Ubiquitin-homology Domain Protein PIC1, Ubiquitin-like Protein UBL1, GAP Modifying Protein 1, GMP1, Sentrin, SMT3C, SMT3H3, UBL1, Small Ubiquitin-related Modifier 2, SUMO-2, Ubiquitin-like Protein SMT3B, SMT3 Homolog 2, Sentrin-2, HSMT3, SUMO-3, SMT3B, SMT3H2, Small Ubiquitin-related Modifier 3, SUMO-3, Ubiquitin-like Protein SMT3A, SMT3 Homolog 1, SUMO-2, SMT3A, SMT3H1) (MaxLight 650) discontinued
Ask
View Details 
GTR15358681 1 Vial
Lentiviral human FYB1 sgRNA gene knockout kit - Lentiviral human FYB1 sgRNA gene knockout kit (100)
Ask
View Details